$11.2 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
-Net income is all revenues minus all expenses including taxes and interest in the last quarter.
$-7.03Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-20.27xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
-Earnings before interest expenses and taxes in the last quarter.
743The number of full time employees.
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
This week could see up to nine companies price their IPOs. Here is a look at the companies looking to go public this week. Codiak Biosciences: Clinical stage biopharmaceutical Codiak Biosciences (N...Benzinga, 8 days ago
Sarepta Therapeutics (NASDAQ:SRPT) perks up 2% premarket on light volume on the heels of updated follow-up data on two of its gene therapy candidates. SRP-Seeking Alpha, 22 days ago
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Robert W Baird Global Healthcare Broker Conference Call September 10, 2020, 14:00 ET Company Participants Ian Estepan - SVP, Corporate Affairs & Chief of St...Seeking Alpha, about 1 month ago